Palvella Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	861	130	-	-
Enterprise Value	820	208	-	-
PB Ratio	26.10	2.15	-	-
P/TBV Ratio	26.10	2.15	-	-
Debt / Equity Ratio	0.41	0.19	-2.08	-1.40
Net Debt / Equity Ratio	-1.23	-1.14	-0.18	-0.71
Quick Ratio	6.38	7.14	3.11	2.78
Current Ratio	6.49	7.33	3.20	2.86
Return on Equity (ROE)	-301.19%	-59.37%	-	-
Return on Assets (ROA)	-47.54%	-18.39%	-61.63%	-
Return on Capital Employed (ROCE)	-55.90%	-18.50%	-228.80%	-167.90%
Earnings Yield	-3.21%	-12.95%	-	-
Buyback Yield / Dilution	-60.51%	-24.08%	68.63%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.